Department of Physiatry, Hospital for Special Surgery, New York, NY, USA.
Biostatistics Core, Hospital for Special Surgery, New York, NY, USA.
PM R. 2021 Nov;13(11):1207-1215. doi: 10.1002/pmrj.12539. Epub 2021 Feb 3.
Menstrual irregularity (MI) is common in female athletes and is a component of the Female Athlete Triad (Triad). Many athletes with the Triad are started on hormonal contraceptives (HC) for MI, but this interferes with the ability to monitor menstrual cycle regularity and can mask other causes of MI. There are limited studies investigating the relationship between MI, HC use, and injury in female collegiate athletes.
To examine the prevalence of and relationship between HC use, MI, and bone stress injuries in female collegiate athletes in the United States.
Cross-sectional study.
Online survey.
1020 U.S. female collegiate athletes (age ≥ 18 years).
Assessment of risk factors for menstrual irregularity and bone stress injuries was conducted via a one-time survey.
HC use, MI, history of stress fractures.
Current HC use prevalence was 65% (95% confidence interval [CI], 61.9%, 67.8%). Of all athletes, 47% reported past MI. Of the athletes who were not currently using HCs, 32% had current MI. Compared with athletes without past MI, more athletes with past MI reported current HC use (73% vs. 57%) and indicated menstrual cycle consistency as the primary reason for use (24% vs. 4%) (P < .001). Additionally, 25% of athletes reported a history of stress fractures, which was associated with lean/aesthetic sports participation (odds ratio [95% CI]: 1.9 [1.4, 2.5]; P < .001) and less oral contraceptive pill (OCP) use (0.7 [0.5, 1.0]; P = .043). Compared with OCPs, injectable HCs were associated with greater odds of a history of stress fractures (4.5[1.6, 12.3]; P = .004).
HC use was prevalent among this cohort of female collegiate athletes, and almost half of the athletes reported past MI. A goal of menstrual cycle regularity was cited by 24% of athletes as a primary reason to use HCs, which shows that more athlete education is needed to avoid masking MI and the Triad with HCs. Further studies elucidating the relationship between HC use, MI, and sports-related injury are warranted.
月经不规律(MI)在女性运动员中很常见,是女性运动员三联征(Triad)的一个组成部分。许多患有三联征的运动员因 MI 开始使用激素避孕药(HC),但这会干扰监测月经周期规律的能力,并可能掩盖 MI 的其他原因。目前,关于美国女性大学生运动员 MI、HC 使用与损伤之间关系的研究有限。
研究美国女性大学生运动员中 HC 使用、MI 和骨应激损伤的流行程度及其相关性。
横断面研究。
在线调查。
1020 名美国女性大学生运动员(年龄≥18 岁)。
通过一次性调查评估月经不规律和骨应激损伤的危险因素。
HC 使用、MI、应力性骨折史。
目前 HC 使用的流行率为 65%(95%置信区间[CI],61.9%,67.8%)。所有运动员中,47%报告有既往 MI。在未使用 HC 的运动员中,32%目前有 MI。与既往无 MI 的运动员相比,既往有 MI 的运动员中更多人报告目前使用 HC(73%比 57%),且表示月经周期一致性是使用的主要原因(24%比 4%)(P<.001)。此外,25%的运动员报告有应力性骨折史,这与参加瘦/美学运动(比值比[95%CI]:1.9[1.4,2.5];P<.001)和较少使用口服避孕药(OCP)(0.7[0.5,1.0];P=.043)有关。与 OCP 相比,注射用 HC 与应力性骨折史的相关性更大(4.5[1.6,12.3];P=.004)。
HC 在该队列的女性大学生运动员中很常见,近一半的运动员报告有既往 MI。24%的运动员表示,保持月经周期规律是使用 HC 的主要原因之一,这表明需要对运动员进行更多教育,以避免用 HC 掩盖 MI 和 Triad。进一步阐明 HC 使用、MI 和与运动相关的损伤之间的关系的研究是必要的。